Pérez de Vega M Jesús, Gómez-Monterrey Isabel, Ferrer-Montiel Antonio, González-Muñiz Rosario
Instituto de Química Médica, IQM-CSIC. Juan de la Cierva 3, 28006 Madrid, Spain.
Dipartimento di Farmacia, Università "Federico II" de Napoli , Via D. Montesano 49, 80131, Naples, Italy.
J Med Chem. 2016 Nov 23;59(22):10006-10029. doi: 10.1021/acs.jmedchem.6b00305. Epub 2016 Aug 1.
TRPM8 ion channels, the primary cold sensors in humans, are activated by innocuous cooling (<28 °C) and cooling compounds (menthol, icilin) and are implicated in sensing unpleasant cold stimuli as well as in mammalian thermoregulation. Overexpression of these thermoregulators in prostate cancer and in other life-threatening tumors, along with their contribution to an increasing number of pathological conditions, opens a plethora of medicinal chemistry opportunities to develop receptor modulators. This Perspective seeks to describe current known modulators for this ion channel because both agonists and antagonists may be useful for the treatment of most TRPM8-mediated pathologies. We primarily focus on SAR data for the different families of compounds and the pharmacological properties of the most promising ligands. Furthermore, we also address the knowledge about the channel structure, although still in its infancy, and the role of the TRPM8 protein signalplex to channel function and dysfunction. We finally outline the potential future prospects of the challenging TRPM8 drug discovery field.
瞬时受体电位香草酸亚型8(TRPM8)离子通道是人类主要的冷感受器,可被无害冷却(<28°C)以及冷却化合物(薄荷醇、异柠檬素)激活,参与感知不愉快的冷刺激以及哺乳动物的体温调节。这些体温调节因子在前列腺癌和其他危及生命的肿瘤中过表达,以及它们在越来越多的病理状况中的作用,为开发受体调节剂带来了大量药物化学机会。本观点文章旨在描述目前已知的该离子通道调节剂,因为激动剂和拮抗剂可能都有助于治疗大多数由TRPM8介导的病症。我们主要关注不同化合物家族的构效关系(SAR)数据以及最有前景配体的药理特性。此外,我们还探讨了关于该通道结构的知识,尽管仍处于起步阶段,以及TRPM8蛋白信号复合体在通道功能和功能障碍中的作用。我们最后概述了具有挑战性的TRPM8药物发现领域潜在的未来前景。